Eli Lilly says will keep animal health business, Reuters reports Eli Lilly (LLY) has no plans to spin off or sell its Elanco animal health business, CEO John Lechleiter says, Reuters reports. Pfizer (PFE) spun off its animal health business earlier this month through an IPO that raised $2.2B. Reference Link
News For LLY;PFE From The Last 14 Days
Check below for free stories on LLY;PFE the last two weeks.